Loading clinical trials...
Loading clinical trials...
An Open-Label, Multicenter, Long-Term Extension Study To Assess The Safety, Efficacy, And Pharmacodynamics Of AT2101 In Adult Patients With Type 1 Gaucher Disease
Conditions
Interventions
afegostat tartrate
Locations
4
United States
Coral Springs, Florida, United States
Decatur, Georgia, United States
Boston, Massachusetts, United States
London, United Kingdom
Start Date
May 11, 2009
Primary Completion Date
May 1, 2012
Completion Date
May 1, 2012
Last Updated
August 15, 2018
NCT07223944
NCT05992532
NCT03333200
NCT06573723
NCT05487599
NCT03190837
Lead Sponsor
Amicus Therapeutics
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions